UMIN ID: UMIN000000664
Registered date:02/04/2007
Supplemental Benefit of ARB in Maintenance of Sinus Rhythm after Left Atrial Ablation in Atrial Fibrillation using Valsartan
Basic Information
Recruitment status | Pending |
---|---|
Health condition(s) or Problem(s) studied | Atrial Fibrillation |
Date of first enrollment | 2007/04/01 |
Target sample size | 180 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | Valsartan40-80mg daily, during the study period. Control |
Outcome(s)
Primary Outcome | A composite of all - reverse remodeling of left atrium and recurrence of atrial fibrillation. |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | 30years-old |
---|---|
Age maximum | 70years-old |
Gender | Male and Female |
Include criteria | |
Exclude criteria | (1)Patients who have renal dysfunction (serum creatinine>=3.0mg/dL or those who are receiving chronic hemodialysis (2) History of drug hypersensitivity to angiotensine II receptor blocker. (3)Patients who have severe liver dysfunction (4)Patents with cerebrovasucular disease (5)History of angioedema (6)History of malignant tumor or life threatening illness of poor prognosis (7)Pregnant or possibly pregnant patients (8)Patents after Cardiovascular surgery (9)Other patients deemed unsuitable as subjects of the study by the treating physician |
Related Information
Primary Sponsor | Department of Cardiovascular Medicine Tohoku University Graduate School of Medicine |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | None |
Secondary ID(s) |
Contact
public contact | |
Name | Koji Kumagai |
Address | 1-1 Seiryou-machi, Sendai-city Japan |
Telephone | |
Affiliation | Tohoku University Graduate School of Medicine Department of Cardiovascular Medicine |
scientific contact | |
Name | Hiroaki Shimokawa |
Address | 1-1 Seiryou-machi, Sendai-city Japan |
Telephone | 022(717)7153 |
Affiliation | Tohoku University Graduate School of Medicine Department of Cardiovascular Medicine |